Nitroglycerin patch use in digital ischemia secondary to sepsis: a case report

Devendrasing Vijaysing Jadhav1, Derek Mendonca2, Suresh Kotinatot1

  • 1Neonatal Intensive Care Unit, Al Jalila Children´s Specialty Hospital, Dubai, United Arab Emirates.

Insights

Sepsis in infants can cause severe complications. A preterm infant

Area of Science:

  • Neonatal Medicine
  • Pediatric Infectious Diseases
  • Vascular Surgery

Background:

  • Sepsis in neonates, particularly preterm infants, presents significant challenges due to immature immune systems.
  • Infants' limited inflammatory response can lead to rapid progression of infection, increasing risks of pneumonia and meningitis.
  • Peripheral ischemic complications are a serious, though less common, manifestation of neonatal sepsis.

Observation:

  • A 26-week preterm infant boy developed acute digital ischemia in his right index finger.
  • The ischemia was progressing towards gangrene, indicating a severe manifestation of septicemia.
  • The infant's immature inflammatory response likely contributed to the rapid progression of the septicemic complication.

Findings:

  • Topical nitroglycerin patch application was utilized to manage the impending peripheral gangrene.
  • This non-invasive treatment successfully alleviated the ischemic condition in the affected digit.
  • No adverse effects were observed during the treatment period, highlighting the safety profile.

Implications:

  • Topical nitroglycerin may be a viable therapeutic option for managing peripheral ischemic complications in neonatal sepsis.
  • Early recognition and intervention are crucial for preventing severe outcomes like gangrene in septic infants.
  • This case underscores the importance of considering diverse clinical presentations of sepsis in preterm neonates.

Related Concept Videos

Angina V: Nursing Management01:20

Angina V: Nursing Management

Angina, a symptom of myocardial ischemia, requires a structured nursing management approach to ensure effective care and prevent complications like myocardial infarction. Comprehensive nursing care involves assessing, diagnosing, planning, implementing interventions, and evaluating outcomes, all tailored to the individual patient's needs.Patient AssessmentNursing assessment begins with a detailed subjective evaluation of symptoms, which typically include chest pain or pressure radiating to the...
123
Angina II: Classification01:27

Angina II: Classification

Angina, also known as angina pectoris, is a chest pain resulting from diminished blood flow to the heart muscle and is often a symptom of coronary artery disease. Angina presents several variants with distinctive attributes, etiologies, and therapeutic approaches. The main types of angina include stable, unstable, variant (Prinzmetal's), microvascular, intractable, and silent ischemia.Stable angina is caused by atherosclerosis, which leads to the formation of plaques that narrow the coronary...
90
Acute Coronary Syndrome V: Nursing Management01:26

Acute Coronary Syndrome V: Nursing Management

Nursing Assessment:Nursing management of acute coronary syndrome (ACS) involves taking the patient's history, focusing on primary complaints such as chest pain, dyspnea, and excessive sweating (diaphoresis), as well as other symptoms like back or jaw pain, nausea, vomiting, palpitations, dizziness, and fatigue. The nurse also reviews the patient's history of cardiac events, risk factors such as hypertension, diabetes, smoking, family history, and current medications.In the objective assessment,...
104
Antianginal Drugs: Nitrates and β-Blockers01:16

Antianginal Drugs: Nitrates and β-Blockers

In cardiovascular health, antianginal drugs combat angina pectoris — a condition marked by chest pain owing to diminished blood flow to the heart.
Organic nitrates,  such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
938
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
45
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
101